Teva Pharma discloses SEC bribery investigation
News | 06 August 2012
NEW YORK (AP) ? Teva Pharmaceutical, the largest generic drug company in the world, said it is the target of a federal bribery investigation into its business in Latin America. Teva said the Securities and Exchange Commission has subpoenaed documents ...
Click on the link to read the full article at Boston.com
(This link will open in a new window)
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Italy's pharma market slump set to continue, warns GlobalData
- Is failure to adopt business process management putting the pharma industry at risk?
